Thomas Nösslinger

4.0k citations
73 papers · 3.1k · 3 hit papers · h-index 24

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Multiple Myeloma Research and Treatments
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 0.5%
    • Myeloproliferative Neoplasms: Diagnosis and Treatment
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Acute Myeloid Leukemia Research 40
    • Multiple Myeloma Research and Treatments 7
    • Chronic Myeloid Leukemia Treatments 7
    • Chronic Lymphocytic Leukemia Research 27
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 14

Thomas Nösslinger

67 papers receiving 3.1k citations

Thomas Nösslinger's Hit Papers

First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia 2023 · 201 citations
2010+6+12Years since publication200400600

Peers

Thomas Nösslinger
Comparison fields: 5 of 70
  • Hematology 2.5k
  • Genetics 1.3k
  • Pathology and Forensic Medicine 512
  • Emergency Medicine 250
  • Orthopedics and Sports Medicine 126
Replace Michael Luebbert with:
Michael Luebbert Germany
Corinna Strupp Germany
Silvia M. M. Magalhães Brazil
Jay T. Backstrom United States
Gitte Birk Kerndrup Denmark
Kenton Wride United States
C.L. Beach United States
Eva Hellström-Lindberg Sweden
Janice M. Hodnefield United States
Rolf Kuse Germany
Thomas Nösslinger relative to Michael Luebbert Germany Michael Luebbert's profile →
Citations per field
00.5×1.5×2×2.3×
Michael Luebbert · 1×
Citations per year

Countries citing papers authored by Thomas Nösslinger

Since Specialization
Citations

This map shows the geographic impact of Thomas Nösslinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Nösslinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Nösslinger more than expected).

Fields of papers citing papers by Thomas Nösslinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Nösslinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Nösslinger. The network helps show where Thomas Nösslinger may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas Nösslinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Nösslinger Line = papers co-authored together Thomas Nösslinger links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.

#Work
1
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients
Hit paper breakdown →
2007633
2
New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge
Hit paper breakdown →
2012554
3
First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia
Hit paper breakdown →
2023201
4 2000142
5 2005136
6 2011122
7 2012108
8 2001102
9 200993
10 199975
11 200465
12 200461
13 200960
14 200259
15 201449
16 200149
17 200848
18 201747
19 201641
20 201340

About Thomas Nösslinger

Thomas Nösslinger is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Oncology and Molecular Biology, having authored 73 papers that have together received 3.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (40 papers), Chronic Lymphocytic Leukemia Research (27 papers), Lymphoma Diagnosis and Treatment (20 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (14 papers), Multiple Myeloma Research and Treatments (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), Acute Lymphoblastic Leukemia research (5 papers) and Retinoids in leukemia and cellular processes (5 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (1.3k citations), Pathology and Forensic Medicine (512 citations), Emergency Medicine (250 citations) and Orthopedics and Sports Medicine (126 citations). Thomas Nösslinger has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Michael Pfeilstöcker, Peter Valent, Reinhard Stauder, Friedrich Wimazal, Aristoteles A. N. Giagounidis, Michael Lübbert, Otto Krieger, Barbara Hildebrandt, Christian Steidl and Christa Fonatsch. Their work appears in journals such as Blood, Annals of Oncology, European Journal of Clinical Investigation, Leukemia and European Journal Of Haematology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact